Patents by Inventor Karen L. Fearon

Karen L. Fearon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME
    Publication number: 20220267772
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Application
    Filed: April 5, 2022
    Publication date: August 25, 2022
    Applicant: TriSalus Life Sciences, Inc.
    Inventors: Dino Dina, Karen L. Fearon, Jason Marshall
  • Immunostimulatory sequence oligonucleotides and methods of using the same
    Patent number: 11312965
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: April 26, 2022
    Assignee: TriSalus Life Sciences, Inc.
    Inventors: Dino Dina, Karen L. Fearon, Jason Marshall
  • IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME
    Publication number: 20190276829
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Application
    Filed: December 18, 2018
    Publication date: September 12, 2019
    Inventors: Dino DINA, Karen L. FEARON, Jason MARSHALL
  • Immunostimulatory sequence oligonucleotides and methods of using the same
    Patent number: 10196643
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Grant
    Filed: August 9, 2016
    Date of Patent: February 5, 2019
    Assignee: Dynavax Technologies Corporation
    Inventors: Dino Dina, Karen L. Fearon, Jason Marshall
  • Human toll-like receptor inhibitors and methods of use thereof
    Patent number: 9868955
    Abstract: Provided herein are human Toll-like receptor (TLR)-inhibitors and methods for use in individuals having an autoimmune disease or an inflammatory disorder. The TLR inhibitors of the present disclosure are polynucleotides comprising an inhibitory motif for one or more of TLR7, TLR8 and TLR9.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: January 16, 2018
    Assignee: Dynavax Technologies Corporation
    Inventors: Cristiana Guiducci, Karen L. Fearon, Franck Barrat
  • IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME
    Publication number: 20170067055
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Application
    Filed: August 9, 2016
    Publication date: March 9, 2017
    Inventors: Dino DINA, Karen L. FEARON, Jason MARSHALL
  • Immunostimulatory sequence oligonucleotides and methods of using the same
    Patent number: 9422564
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: August 23, 2016
    Assignee: Dynavax Technologies Corporation
    Inventors: Dino Dina, Karen L. Fearon, Jason Marshall
  • Human toll-like receptor inhibitors and methods of use thereof
    Patent number: 9228184
    Abstract: Provided herein are human Toll-like receptor (TLR)-inhibitors and methods for use in individuals having an autoimmune disease or an inflammatory disorder. The TLR inhibitors of the present disclosure are polynucleotides comprising an inhibitory motif for one or more of TLR7, TLR8 and TLR9.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 5, 2016
    Assignee: Dynavax Technologies Corporation
    Inventors: Cristiana Guiducci, Karen L. Fearon, Franck Barrat
  • CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-IV
    Publication number: 20150297737
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: April 22, 2015
    Publication date: October 22, 2015
    Inventors: Karen L. FEARON, Dino Dina, Stephen F. Tuck
  • HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20150252363
    Abstract: Provided herein are human Toll-like receptor (TLR)-inhibitors and methods for use in individuals having an autoimmune disease or an inflammatory disorder. The TLR inhibitors of the present disclosure are polynucleotides comprising an inhibitory motif for one or more of TLR7, TLR8 and TLR9.
    Type: Application
    Filed: September 27, 2013
    Publication date: September 10, 2015
    Inventors: Cristiana Guiducci, Karen L. Fearon, Franck Barrat
  • IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME
    Publication number: 20150132293
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Application
    Filed: October 20, 2014
    Publication date: May 14, 2015
    Inventors: Dino DINA, Karen L. FEARON, Jason MARSHALL
  • Chimeric immunomodulatory compounds and methods of using the same-IV
    Patent number: 9028845
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: May 12, 2015
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Immunostimulatory sequence oligonucleotides and methods of using the same
    Patent number: 8871732
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Grant
    Filed: April 3, 2012
    Date of Patent: October 28, 2014
    Assignee: Dynavax Technologies Corporation
    Inventors: Dino Dina, Karen L. Fearon, Jason Marshall
  • CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-IV
    Publication number: 20140127255
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: September 18, 2013
    Publication date: May 8, 2014
    Applicant: DYNAVAX TECHNOLOGIES CORPORATION
    Inventors: Karen L. FEARON, Dino DINA, Stephen F. TUCK
  • HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20140094504
    Abstract: Provided herein are human Toll-like receptor (TLR)-inhibitors and methods for use in individuals having an autoimmune disease or an inflammatory disorder. The TLR inhibitors of the present disclosure are polynucleotides comprising an inhibitory motif for one or more of TLR7, TLR8 and TLR9.
    Type: Application
    Filed: March 15, 2013
    Publication date: April 3, 2014
    Applicant: Dynavax Technologies Corporation
    Inventors: Cristiana GUIDUCCI, Karen L. FEARON, Franck BARRAT
  • Biodegradable immunomodulatory formulations and methods for use thereof
    Patent number: 8669237
    Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMP/MC) complexes. The IMP/MC complexes may be covalently or non-covalently bound, and feature a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or nanocarrier.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: March 11, 2014
    Assignee: Dynavax Technologies Corporation
    Inventors: Gary Van Nest, Stephen Tuck, Karen L. Fearon, Dino Dina
  • Chimeric immunomodulatory compounds and methods of using the same-IV
    Patent number: 8597665
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: December 3, 2013
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Immunomodulatory compositions, formulations, and methods for use thereof
    Patent number: 8586555
    Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMO/MC) complexes comprising 3-6mer immunomodulatory oligonucleotides. The IMO/MC complexes may be covalently or non-covalently bound. Also provided are immunomodulatory compositions comprising a 3-6mer IMO encapsulated in an MC.
    Type: Grant
    Filed: March 2, 2009
    Date of Patent: November 19, 2013
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina
  • IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME
    Publication number: 20130142814
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Application
    Filed: April 3, 2012
    Publication date: June 6, 2013
    Inventors: Dino Dina, Karen L. Fearon, Jason Marshall
  • Immunomodulatory polynucleotides and methods of using the same
    Patent number: 8372413
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: February 12, 2013
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina